Trial intelligence / Profile preview

Pilot placebo-controlled trial of intravenous salbutamol in acute respiratory distress syndrome

2005-005951-16Phase 4Terminated

Sponsor
Hospital Universitario
Start
Jun 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing Intravenous salbutamol with Placebo (2 arms). Primary endpoint: Change in exhaled air leukotriene B4 levels. Started Jun 2006; status: terminated.

02

Drugs

salbutamol
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on 2005-005951-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-005951-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call